EC Number |
Inhibitors |
Structure |
---|
4.1.1.28 | (2S)-2-amino-3-(3-hydroxyphenyl)-2-methylpropanoic acid |
- |
|
4.1.1.28 | (2S)-2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid |
- |
|
4.1.1.28 | (S)-alpha-(fluoromethyl)tryptophan |
the suicide substrate effectively inhibits TDC activity extracted from rice leaves infected by Bipolaris oryzae and the inhibition rate increases dependent on preincubation time |
|
4.1.1.28 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
MPTP, after 7 days of treatment, AAAD activities are decreased by more than 50% in the mouse striatum |
|
4.1.1.28 | 2,2'-dipyridyl |
weak |
|
4.1.1.28 | 2,3,4-Trihydroxybenzylhydrazine |
- |
|
4.1.1.28 | 2-Phenylethylamine |
competitive inhibition, 80% inhibition at 0.5 mM |
|
4.1.1.28 | 2-[1-[4-hydroxy-5-[3-(3-hydroxy-4-methoxyphenyl)propyl]-2-methoxyphenyl]-3-(4-hydroxy-3-methoxyphenyl)propyl]-5-methoxycyclohexa-2,5-diene-1,4-dione |
inhibitor isolated from Euonymus glabra Roxb. |
|
4.1.1.28 | 2-[[(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)sulfonyl]amino]-N-phenylbenzamide |
competitive. Inhibitor is unable to bind free pyridoxal 5'-phosphate, and predicted to not cross the blood-brain barrier |
|
4.1.1.28 | 3'-hydroxybenzylhydrazine |
NSD-1015, a central aromatic L-amino acid decarboxylase inhibitor |
|